Spots Global Cancer Trial Database for stage iii rectal cancer
Every month we try and update this database with for stage iii rectal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | NCT00025337 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | bevacizumab oxaliplatin leucovorin calc... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer | NCT00134069 | Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | sorafenib tosyl... cetuximab irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | NCT00613080 | Colorectal Canc... | capecitabine oxaliplatin resection radiation thera... FOLFOX | 18 Years - | Radiation Therapy Oncology Group | |
| Gemcitabine in Treating Patients With Advanced Colorectal Cancer | NCT00007943 | Colorectal Canc... | gemcitabine hyd... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed | NCT00002551 | Colorectal Canc... | fluorouracil leucovorin calc... levamisole hydr... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer | NCT00005076 | Colorectal Canc... | cetuximab irinotecan hydr... | 18 Years - | University of Alabama at Birmingham | |
| Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer | NCT00002828 | Colorectal Canc... | fluorouracil raltitrexed | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Colorectal Cancer | NCT00006103 | Colorectal Canc... | fluorouracil irinotecan hydr... leucovorin calc... | - | Alliance for Clinical Trials in Oncology | |
| Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer | NCT00084591 | Colorectal Canc... | capecitabine conventional su... neoadjuvant the... radiation thera... | 18 Years - | Fox Chase Cancer Center | |
| Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | NCT00296608 | Colorectal Canc... | fluorouracil leucovorin calc... conventional su... radiation thera... | 18 Years - 75 Years | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer | NCT00002801 | Colorectal Canc... | leucovorin calc... tegafur-uracil radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer | NCT00462501 | Colorectal Canc... | bevacizumab fluorouracil leucovorin calc... oxaliplatin conventional su... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | NCT00006001 | Colorectal Canc... | semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | NCT00026273 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 75 Years | Pfizer | |
| Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | NCT00138177 | Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... Unspecified Adu... | oxaliplatin leucovorin calc... vorinostat fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | NCT01164215 | Colorectal Canc... Diarrhea Neutropenia | fluorouracil leucovorin oxaliplatin | - | UNC Lineberger Comprehensive Cancer Center | |
| Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer | NCT00134069 | Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | sorafenib tosyl... cetuximab irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer | NCT00003063 | Colorectal Canc... | recombinant int... fluorouracil leucovorin calc... levamisole hydr... | - 75 Years | National Cancer Institute (NCI) | |
| Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer | NCT00005640 | Colorectal Canc... | Preoperative En... Technetium Tc 9... Gamma Probe Biopsy of Senti... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer | NCT00373022 | Anxiety Disorde... Colorectal Canc... Depression Psychosocial Ef... | exercise interv... flow cytometry laboratory biom... management of t... psychosocial as... quality-of-life... | 18 Years - | University of Arizona | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer | NCT00081237 | Colorectal Canc... | OSI-7904L oxaliplatin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer | NCT00081289 | Colorectal Canc... | Radiation Thera... Capecitabine 16... Capecitabine 12... Irinotecan Oxaliplatin Surgery Folinic Acid Fluorouracil Oxaliplatin | 18 Years - | Radiation Therapy Oncology Group | |
| Genetic Study of Young Patients With Colorectal Cancer | NCT00044967 | Colorectal Canc... | microsatellite ... | 18 Years - 49 Years | Alliance for Clinical Trials in Oncology | |
| Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer | NCT00296062 | Colorectal Canc... Unspecified Adu... | bevacizumab capecitabine irinotecan hydr... oxaliplatin | 18 Years - | Case Comprehensive Cancer Center | |
| Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers | NCT00684801 | Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | questionnaire a... quality-of-life... | 18 Years - | Case Comprehensive Cancer Center | |
| Genetic Study of Patients and Families With a History of Colorectal Cancer | NCT00003648 | Colorectal Canc... | DNA stability a... gene rearrangem... | - | Alliance for Clinical Trials in Oncology | |
| Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed | NCT00002523 | Colorectal Canc... | fluorouracil leucovorin calc... conventional su... radiation thera... | - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | NCT00625625 | Colorectal Canc... | isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym... | 18 Years - | National Cancer Institute (NCI) | |
| Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | NCT00217711 | Colorectal Canc... | Capecitabine irinotecan hydr... oxaliplatin | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
| Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer | NCT00628368 | Colorectal Canc... Esophageal Canc... | gene expression... mutation analys... polymorphism an... laboratory biom... biopsy endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | NCT00005586 | Colorectal Canc... | L-leucovorin fluorouracil adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | NCT00025532 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | iodine I 131 mo... | 19 Years - | University of California, San Francisco | |
| Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | NCT00296608 | Colorectal Canc... | fluorouracil leucovorin calc... conventional su... radiation thera... | 18 Years - 75 Years | Federation Francophone de Cancerologie Digestive | |
| Laparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can Be Removed By Surgery | NCT01196000 | Recurrent Recta... Stage I Rectal ... Stage II Rectal... Stage III Recta... | conventional la... robotic-assiste... quality-of-life... questionnaire a... | 18 Years - | City of Hope Medical Center | |
| Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer | NCT00003344 | Colorectal Canc... | irinotecan hydr... radiation thera... | 18 Years - 120 Years | Medical University of South Carolina | |
| External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer | NCT00869570 | Colorectal Canc... | capecitabine sorafenib tosyl... radiation thera... | 18 Years - 120 Years | Swiss Group for Clinical Cancer Research | |
| Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | NCT00433576 | Adenocarcinoma ... Adenocarcinoma ... Stage I Colon C... Stage I Rectal ... Stage II Colon ... Stage II Rectal... Stage III Colon... Stage III Recta... | resveratrol pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer | NCT00478010 | Colorectal Canc... Pancreatic Canc... Psychosocial Ef... | counseling inte... study of socioe... psychosocial as... quality-of-life... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal Cancer | NCT00856115 | Colorectal Canc... | medical chart r... questionnaire a... study of socioe... survey administ... | 21 Years - | Case Comprehensive Cancer Center | |
| Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed | NCT00003422 | Colorectal Canc... | fluorouracil leucovorin calc... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 75 Years | National Cancer Institute (NCI) | |
| Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal Cancer | NCT00560365 | Colorectal Canc... | laboratory biom... computed tomogr... magnetic resona... quality-of-life... | 50 Years - | National Cancer Institute (NCI) | |
| Gemcitabine in Treating Patients With Advanced Colorectal Cancer | NCT00007943 | Colorectal Canc... | gemcitabine hyd... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | NCT00897793 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer | venipuncture radiation thera... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer | NCT00002801 | Colorectal Canc... | leucovorin calc... tegafur-uracil radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | NCT00003594 | Colorectal Canc... | irinotecan fluorouracil leucovorin calc... oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer | NCT00003063 | Colorectal Canc... | recombinant int... fluorouracil leucovorin calc... levamisole hydr... | - 75 Years | National Cancer Institute (NCI) | |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | NCT00010270 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
| DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma | NCT00080834 | Colorectal Canc... | DJ-927 | 18 Years - | Daiichi Sankyo | |
| Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer | NCT00081289 | Colorectal Canc... | Radiation Thera... Capecitabine 16... Capecitabine 12... Irinotecan Oxaliplatin Surgery Folinic Acid Fluorouracil Oxaliplatin | 18 Years - | Radiation Therapy Oncology Group | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum | NCT00081224 | Colorectal Canc... | capecitabine celecoxib radiation thera... surgery | 18 Years - | Alliance for Clinical Trials in Oncology | |
| S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery | NCT00974389 | Colorectal Canc... | bevacizumab tegafur-gimerac... | 20 Years - 80 Years | National Cancer Institute (NCI) | |
| Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer | NCT00077259 | Colorectal Canc... | epothilone D | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma | NCT00080834 | Colorectal Canc... | DJ-927 | 18 Years - | Daiichi Sankyo | |
| Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | NCT00280176 | Colorectal Canc... | bortezomib fluorouracil radiation thera... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | NCT00369109 | Breast Cancer Colorectal Canc... Pancreatic Canc... | biologic sample... immunohistochem... laboratory biom... biopsy | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer | NCT00052559 | Adenocarcinoma ... Stage II Rectal... Stage III Recta... | bevacizumab fluorouracil external beam r... therapeutic con... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | NCT00625625 | Colorectal Canc... | isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym... | 18 Years - | National Cancer Institute (NCI) | |
| MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer | NCT00602329 | Colorectal Canc... | bevacizumab fluorouracil leucovorin calc... oxaliplatin | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer | NCT00002893 | Colorectal Canc... | fluorouracil leucovorin calc... raltitrexed | - | National Cancer Institute (NCI) | |
| Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | NCT01190462 | Colorectal Canc... | cetuximab simvastatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy | NCT01099449 | Chemotherapeuti... Colorectal Canc... Neuropathy Neurotoxicity | calcium glucona... magnesium sulfa... placebo oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers | NCT00410579 | Colorectal Canc... Fatigue Long-term Effec... Pain Psychosocial Ef... | Telephone inter... | - | NSABP Foundation Inc | |
| Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer | NCT00003344 | Colorectal Canc... | irinotecan hydr... radiation thera... | 18 Years - 120 Years | Medical University of South Carolina | |
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | NCT00025337 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | bevacizumab oxaliplatin leucovorin calc... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | NCT00436410 | Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma | colloidal gold-... electron micros... pharmacological... conventional su... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer | NCT00462501 | Colorectal Canc... | bevacizumab fluorouracil leucovorin calc... oxaliplatin conventional su... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma | NCT00075556 | Colorectal Canc... | capecitabine conventional su... neoadjuvant the... radiation thera... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy | NCT00280761 | Colorectal Canc... | capecitabine 5-fluorouracil Surgical Resect... Radiation thera... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | NCT01164215 | Colorectal Canc... Diarrhea Neutropenia | fluorouracil leucovorin oxaliplatin | - | UNC Lineberger Comprehensive Cancer Center | |
| Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer | NCT00004195 | Colorectal Canc... | eniluracil conventional co... | 19 Years - 80 Years | University of Alabama at Birmingham | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | NCT00027534 | Breast Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Ovarian Cancer Pancreatic Canc... Testicular Germ... | TRICOM-CEA(6D) | 18 Years - | Duke University | |
| Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | NCT00006366 | Colorectal Canc... | fluorouracil irinotecan hydr... conventional su... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
